Company Filing History:
Years Active: 2019-2024
Title: Innovations and Contributions of Inventor Nicole Okeley
Introduction
Nicole Okeley is a prominent inventor based in Bothell, WA (US), known for her significant contributions to the field of biotechnology. With a total of three patents to her name, she has made remarkable strides in developing innovative solutions for cancer treatment and drug delivery systems.
Latest Patents
One of her latest patents is titled "Selective drug release from internalized conjugates of biologically active compounds." This invention focuses on conjugates of biologically active compounds that include a sequence of amino acids with a tripeptide. This tripeptide allows for selective cleavage by tumor tissue homogenate, facilitating the release of free drugs and improving biodistribution into tumor tissues compared to normal tissues. Another notable patent is "T cells with reduced surface fucosylation and methods of making and using the same." This patent outlines methods for producing T cells with reduced surface fucosylation, which can be utilized in adoptive cell therapy, particularly for cancer treatment.
Career Highlights
Throughout her career, Nicole Okeley has worked with leading companies in the biotechnology sector, including Seagen Inc. and Seattle Genetics, Inc. Her work has been instrumental in advancing therapeutic strategies that target cancer cells more effectively.
Collaborations
Nicole has collaborated with notable professionals in her field, including Noah Bindman and Peter Senter. These collaborations have contributed to her innovative research and development efforts.
Conclusion
Nicole Okeley's work exemplifies the impact of innovation in biotechnology, particularly in cancer treatment and drug delivery. Her patents reflect her commitment to improving therapeutic outcomes for patients in need.